ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations … | News
Short seller’s Characterization of ASCENIV’s Competitive Position Reflects Blatant Misunderstanding of ADMA’s Business and Its Role as Late-line…